Denali Therapeutics Inc. DNLI
Denali Therapeutics Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | -59.5% | -314.2% | -607.8% | 18.7% | -799.1% | -35.9% | — |
| Net margin | — | — | -43.9% | -300.6% | -597.2% | 21.2% | -740.7% | -28.1% | — |
| FCF margin | — | — | -112.2% | -242.1% | -451.9% | 123.1% | -635.3% | 36.2% | — |
| Return on assets | -44.8% | -30.8% | -12.6% | -22.3% | -20.7% | 4.4% | -35.7% | -5.5% | -18.1% |
| Return on equity | -50.6% | -34.4% | -14.1% | -31.3% | -30.2% | 6.2% | -50.0% | -6.6% | -18.9% |
| Current ratio | 9.16 | 8.46 | 13.65 | 3.77 | 2.37 | 20.86 | 9.48 | 14.67 | 28.92 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.